Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.75

-1.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: T. Mann who wrote (94)	4/12/1997 4:59:00 PM
From: Douglas	of 455

Thanks. The Reuters' story was very interesting. Thanks for the invite to the GILD thread, but I'm in so deep with Procept that I'll have to stay here. I'll probably try to sell my shares on any strength. My performance with biotechnology stocks hasn't been stellar. If you read anything about Gilead's vaginal gel please give me a call. The article said that Gilead also tested a vaginal gel form of the drug PMPA in animals, which was found to block the spread of the Human immunodeficiency virus during sexual activity. Gilead plans to begin similar studies in humans later this year in collaboration with the National Institutes of Health in Bethesda, Maryland. Procept mentioned in their 10K that discussions are underway with the National Institute of Health and the British Medical Research Council to secure support for the clinical program. Procept's Phase I clinical trials to assess vaginal irritation in healthy female volunteers began in January,1997 in Antwerp, Belgium and London, U.K. If Procept has a leading drug candidate as they claim, it is critical that they continue to make rapid progress ahead of Gilead. All they need $$$$.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next